WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women
Title: Comparative Effectiveness of Pedometer-Based Walking Interventions: WalkMore
1 other identifier
interventional
115
1 country
1
Brief Summary
The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2012
CompletedFirst Posted
Study publicly available on registry
January 27, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedSeptember 15, 2022
September 1, 2022
3.8 years
January 18, 2012
September 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resting systolic blood pressure
Measured in the seated position using AHA blood pressure measurement guidelines
3 Months
Secondary Outcomes (5)
Resting diastolic blood pressure
3 Months
Accelerometry
3 Months
Brachial Ultrasound
3 Months
Waist Circumference
3 Months
Walking gait
3 Months
Study Arms (3)
Basic Pedometry Intervention
EXPERIMENTALBasic pedometry intervention: Participants will have a goal of obtaining 10,000 steps/day (with no direction with regards to walking intensity/speed/cadence)
Enhanced Pedometry Intervention
EXPERIMENTALEnhanced pedometry Intervention: Participants will have the goal of obtaining 10,000 steps/day and at least 30 minutes in moderate intensity (i.e., at a cadence of at least 100 steps/min);
Control Group
PLACEBO COMPARATORControl group: Will maintain their usual activity and return for follow-up measures
Interventions
Participants will have the goal of obtaining 10,000 steps/day. In addition, participants will attend a meeting once a week with study staff, during which pedometers will be checked, and staff will provide a behavioral intervention to improve physical activity levels
Intensity Enhanced Pedometry: Participants will have the goal of obtaining 10,000 steps/day at least 30 minutes in moderate intensity (i.e., at a cadence of at least 100 steps/min). In addition, participants will attend a meeting once a week with study staff, during which pedometers will be checked, and the staff will provide a behavioral intervention to improve physical activity levels.
Maintain usual physical activity, and return for follow-up measures.
Eligibility Criteria
You may qualify if:
- Woman between 45-74 years of age
- Have not had a menstrual period for at least 12 months
- Are not regularly physically active (self-reported non-exerciser for previous 6 months)
- Have a body mass index (BMI) between 25-45 kg/m2
- Have high normal blood pressure or (systolic pressure of 130-179 mmHg or a diastolic pressure of 85-99 mmHg)
- Not limited in your ability to walk
- Understand these criteria
- Are willing to provide informed consent
- Willing to be randomized to either type of walking intervention or a control group being studied, and are willing to follow the protocol for the group to which they have been assigned
You may not qualify if:
- Have a past history and/or physical examination or laboratory findings of a medical condition including (but not limited to):
- Have any medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise
- Have been diagnosed with diabetes
- Blood pressure is greater than 179 mmHg systolic or 99 mmHg diastolic.
- Participating in another research study which may effect the results of WalkMore
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pennington Biomedical Research Centerlead
- American Heart Associationcollaborator
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Related Publications (2)
Tudor-Locke C, Schuna JM, Swift DL, Dragg AT, Davis AB, Martin CK, Johnson WD, Church TS. Evaluation of Step-Counting Interventions Differing on Intensity Messages. J Phys Act Health. 2020 Jan 1;17(1):21-28. doi: 10.1123/jpah.2018-0439.
PMID: 31698336DERIVEDTudor-Locke C, Swift DL, Schuna JM Jr, Dragg AT, Davis AB, Martin CK, Johnson WD, Church TS. WalkMore: a randomized controlled trial of pedometer-based interventions differing on intensity messages. BMC Public Health. 2014 Feb 15;14:168. doi: 10.1186/1471-2458-14-168.
PMID: 24528783DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catrine Tudor-Locke, PhD
Pennington Biomedical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2012
First Posted
January 27, 2012
Study Start
May 1, 2012
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
September 15, 2022
Record last verified: 2022-09